Hasta la próxima

Auto reproducción

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 vistas • 07/03/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción